SCHEMBL9535544

SCHEMBL9535544

CCn1c(=O)cc(O)c2ccccc21

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 7/20 1.00
ALDH1A1 P00352 10/20 0.72
MAPT P10636 4/20 0.67
MEN1 O00255 2/20 0.67
KMT2A Q03164 2/20 0.67
SMN1; SMN2 Q16637 1/20 0.67
PKM P14618 1/20 0.57
RCE1 Q9Y256 1/20 0.54
CYP1A2 P05177 2/20 0.52
CYP3A4 P08684 2/20 0.52
CYP2C19 P33261 2/20 0.52
HPGD P15428 4/20 0.50
LMNA P02545 3/20 0.50
CYP2D6 P10635 1/20 0.50
CYP2C9 P11712 1/20 0.50
PGR P06401 1/20 0.50
HTT P42858 3/20 0.49
HSD17B10 Q99714 1/20 0.49
RECQL P46063 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7462175 0.87 ALDH1A1 (0.83) KDM4EALDH1A1MAPTMEN1KMT2A
SCHEMBL1790843 0.84 ALDH1A1 (1.00) KDM4EALDH1A1MAPTMEN1KMT2A
SCHEMBL9254043 0.82 ALDH1A1 (0.89) KDM4EALDH1A1MAPTMEN1KMT2A
SCHEMBL9262842 0.82 ALDH1A1 (0.89) KDM4EALDH1A1MAPTMEN1KMT2A
SCHEMBL30197876 0.82 ALDH1A1 (0.89) KDM4EALDH1A1MAPTMEN1KMT2A
SCHEMBL11828707 0.81 ALDH1A1 (0.70) KDM4EALDH1A1MAPTMEN1KMT2A
SCHEMBL17066941 0.81 MEN1 (0.69) KDM4EALDH1A1MAPTMEN1KMT2A
SCHEMBL30367071 0.81 MEN1 (0.69) KDM4EALDH1A1MAPTMEN1KMT2A
SCHEMBL11826856 0.80 ALDH1A1 (0.68) KDM4EALDH1A1MAPTMEN1KMT2A
SCHEMBL1523842 0.80 ALDH1A1 (1.00) KDM4EALDH1A1MAPTMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-110041306-A 4- hydroxyl -2- quinolone-nitrogen-(4- quinazolinone) -3- carboxamides derivatives 中国医学科学院药物研究所 2019-07-23 CN disclosed
US-20180201583-A1 QUINOLINONE OR QUINAZOLINONE COMPRISING ANTIBIOFILM COMPOSITIONS, COMPOUNDS AND METHODS AND USES RELATING THERETO UNIVERSITY COLLEGE CORK - NATIONAL UNIVERSITY OF IRELAND (IE) 2018-07-19 US disclosed
US-5254595-A Aryloxypropanolaminotetralins, a process for their preparation and pharmaceutical compositions containing them ELF SANOFI (FR) 1993-10-19 US disclosed
EP-0375560-B1 ARYLOXYPROPANOLAMINOTETRALINES, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAME ELF SANOFI (FR) 1993-05-12 EP disclosed
EP-0375560-A1 Aryloxypropanolaminotetralines, process for their preparation and pharmaceutical compositions containing same ELF SANOFI (FR) 1990-06-27 EP disclosed
US-4874848-A FOR DYEING WOOL, LEATHER, POLYAMIDES BLACK OR BROWN CIBA-GEIGY CORPORATION (US) 1989-10-17 US disclosed
US-4661587-A Bis 1:2 chromium complexes of disazo and azo or azomethine dyes CIBA-GEIGY CORPORATION (US) 1987-04-28 US disclosed
US-4652631-A LEATHER, WOOL, POLYAMIDES CIBA-GEIGY CORPORATION (US) 1987-03-24 US disclosed
US-4650859-A WOOL,POLYAMIDES, LEATHER CIBA-GEIGY CORPORATION (US) 1987-03-17 US disclosed
US-4563193-A WOOL, POLYAMIDES, LEATHER CIBA GEIGY CORPORATION (US) 1986-01-07 US disclosed
US-4502860-A WOOL, POLYAMIDES, LEATHER CIBA-GEIGY CORPORATION (US) 1985-03-05 US disclosed
EP-0012112-B1 PRESSURE-SENSITIVE OR HEAT-SENSITIVE RECORDING MATERIAL CIBA-GEIGY AG (CH) 1983-10-05 EP disclosed
US-4291901-A Pressure-sensitive or heat-sensitive recording material CIBA-GEIGY CORPORATION (US) 1981-09-29 US disclosed
EP-0012112-A1 Pressure-sensitive or heat-sensitive recording material CIBA-GEIGY AG (CH) 1980-06-11 EP disclosed
US-4101543-A DYES FOR CELLULOSE ACETATES, AROMATIC POLYESTERS OR POLYAMIDES PRODUITS CHIMIQUES UGINE KUHLMANN (FR) 1978-07-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180201583-A1 QUINOLINONE OR QUINAZOLINONE COMPRISING ANTIBIOFILM COMPOSITIONS, COMPOUNDS AND METHODS AND USES RELATING THERETO QSOX1, LPO, NQO2 KDM4E 3548/4885ALDH1A1 544/4885MAPT 4709/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.